Long-acting β2-adrenoceptor agonists: increased risk of death?

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2005年 / 1072卷 / 1期
关键词：
Asthma; Advisory Committee; Interim Analysis; Salmeterol; Formoterol;
D O I：
10.2165/00128415-200510720-00001
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2 / 2
相关论文
共 50 条
  • [41] Long-acting β2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells
    Kaur, Manminder
    Chivers, Joanna E.
    Giembycz, Mark A.
    Newton, Robert
    MOLECULAR PHARMACOLOGY, 2008, 73 (01) : 203 - 214
  • [42] THE THERAPEUTIC POTENTIAL OF LONG-ACTING BETA-2-ADRENOCEPTOR AGONISTS IN ALLERGIC INFLAMMATION
    JOHNSON, M
    VARDEY, CJ
    WHELAN, CJ
    CLINICAL AND EXPERIMENTAL ALLERGY, 1992, 22 (02): : 177 - 181
  • [43] Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD
    Monaco, Thomas J.
    Hanania, Nicola A.
    EXPERT OPINION ON EMERGING DRUGS, 2017, 22 (03) : 285 - 299
  • [44] LONG-ACTING BETA-2-ADRENOCEPTOR AGONISTS - A NEW PERSPECTIVE IN THE TREATMENT OF ASTHMA
    LOFDAHL, CG
    CHUNG, KF
    EUROPEAN RESPIRATORY JOURNAL, 1991, 4 (02) : 218 - 226
  • [45] Some pharmacodynamic aspects on long-acting beta-adrenoceptor agonists
    Waldeck, B
    GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM, 1996, 27 (04): : 575 - 580
  • [46] Effects of a single long-acting muscarinic antagonist agent and a long-acting muscarinic antagonist/long-acting β2-adrenoceptor agonist combination on lung function and symptoms in untreated COPD patients in Japan
    Yamada, Hideyasu
    Hida, Norihito
    Hizawa, Nobuyuki
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018, 13 : 3141 - 3147
  • [47] Long-Acting β2-Adrenoceptor Agonists Do Not Enhance Glucocorticoid Activity By Increasing Glucocorticoid Receptor Expression Or Translocation In Beas-2b Cells
    Rider, C. F.
    Yan, D.
    Miller-Larsson, A.
    Giembycz, M.
    Newton, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [48] Induction Of Regulator Of G-Protein Signalling (RGS) 2 By Long-Acting β2-Adrenoceptor Agonists Is A Novel Genomic Mechanism Of Bronchoprotection That Is Enhanced By Glucocorticoids
    Holden, N. S.
    Bell, M. J.
    Rider, C. F.
    Siderovski, D. P.
    Heximer, S. P.
    Leigh, R.
    Johnson, M.
    Giembycz, M. A.
    Newton, R.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [49] Design-driven LO: The discovery of new ultra long acting dibasic β2-adrenoceptor agonists
    Connolly, Stephen
    Alcaraz, Lilian
    Bailey, Andrew
    Cadogan, Elaine
    Christie, Jadeen
    Cook, Anthony R.
    Fisher, Adrian J.
    Hill, Stephen
    Humphries, Alexander
    Ingall, Anthony H.
    Kane, Zoe
    Paine, Stuart
    Pairaudeau, Garry
    Stocks, Michael J.
    Young, Alan
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2011, 21 (15) : 4612 - 4616
  • [50] Abediterol (las100977) Demonstrates A Higher Potency And A Long Duration Of Action In Comparison With Long-Acting β2-Adrenoceptor Agonists In A Guinea Pig Bronchoconstriction Model
    De Alba, J.
    Otal, R.
    Fernandez-Blanco, J.
    Aparici, M.
    Puig, C.
    Gavalda, A.
    Miralpeix, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
12345